Cardiff Oncology Inc (CRDF)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $56.49M
Last updated: Nov 17, 2026 at 11:04 AM ET
Cardiff Oncology Inc (CRDF) Competitors
The companies most similar to Cardiff Oncology are Oncolytics Biotech (ONCY), Champions Oncology (CSBR) and ImageneBio (IMA). By market cap, Cardiff Oncology ranks 6th of the 13 companies on this page; Nkarta (NKTX) is the largest at $85.23M.
Peer Comparison
CRDF's revenue growth of -14.1% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology (CRDF) | $56.49M | N/A | 115.5x | 0.0% | N/A | -14.1% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Champions Oncology Inc (CSBR) | $65.49M | N/A | 1.0x | -1.9% | N/A | 8.8% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Nkarta Inc (NKTX) | $85.23M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Gossamer Bio Inc (GOSS) | $67.10M | N/A | 0.9x | -159.5% | 147.4% | 189.1% | 0.00% |
| RenovoRx Inc (RNXT) | $50.18M | N/A | 16.6x | 0.0% | N/A | 300.8% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Cognition Therapeutics Inc (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $50.87M | 4.1x | 1.3x | 0.0% | 67.7% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Cardiff Oncology, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| Champions Oncology Inc (CSBR) | Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. | CSBR competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Nkarta Inc (NKTX) | Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and markets cell therapies for the treatment of cancer. | NKTX competitors |
| Gossamer Bio Inc (GOSS) | Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing... | GOSS competitors |
| RenovoRx Inc (RNXT) | RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. | RNXT competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Cognition Therapeutics Inc (CGTX) | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting... | CGTX competitors |
Frequently Asked Questions About CRDF
Who are Cardiff Oncology's main competitors?
The companies most similar to Cardiff Oncology include Oncolytics Biotech (ONCY), Champions Oncology (CSBR), ImageneBio (IMA), Nkarta (NKTX) and Gossamer Bio (GOSS), listed from the closest match.
Who is Cardiff Oncology's biggest competitor?
Nkarta (NKTX) is the largest of the similar companies at $85.23M; Oncolytics Biotech (ONCY) is the closest match by business profile, size, sector and industry.
How does CRDF stock compare with its competitors?
CRDF's P/S is 115.5x against a peer median of 1.3x; its net margin is 0.0% against a peer median of 0.0%.
Which of Cardiff Oncology's competitors pays a higher dividend?
Cardiff Oncology pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Cardiff Oncology bigger than its competitors?
No. Cardiff Oncology is 6th by market cap among the 13 companies on this page; the largest is Nkarta (NKTX) at $85.23M.
CRDF pages: Overview, Earnings, Forecast, Financials, Competitors